Pneumococcal Vaccines Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Pneumococcal Vaccines Market to 2027 - Global Analysis and Forecasts by Dosage (Single Dose Vial, Pre-Filled Syringe); End User (Children aged 2 to 10, Adults aged 10 to 64, Geriatric aged more than 65)

Report Code: TIPRE00004313 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Pneumococcal Vaccines are used against streptococcus pneumonia. Pneumococcal can result in pneumonia, bacteremia pneumonia, bacteremia, meningitis, bloodstream infection and middle Ear infection.

MARKET DYNAMICS
The Pneumococcal Vaccines Market is anticipated to grow in the forecast period owing to driving factors such as increasing government and private organizations to provide vaccination, low-cost of the pneumococcal vaccines, developments and advancements in the vaccines, increasing awareness among the parents regarding vaccination, and funding for development of new vaccines. Nevertheless, slow introduction of the vaccines in low economic countries, less awareness among the older population and low immunization coverage for pneumococcal vaccines is expected to hinder the market growth during the forecast period.

MARKET SCOPE
The "Global Pneumococcal Vaccines Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Pneumococcal Vaccines Market with detailed market segmentation by Dosage, End User and geography. The global Pneumococcal Vaccines Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Pneumococcal Vaccines Market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Pneumococcal Vaccines Market is segmented on the basis of Dosage and End User. Based on Dosage the market is segmented into Single Dose Vial and Pre-Filled Syringe. Based on End User the market is segmented into Children aged 2 to 10, Adults aged 10 to 64, Geriatric aged more than 65.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Pneumococcal Vaccines Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Pneumococcal Vaccines Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Pneumococcal Vaccines Market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Pneumococcal Vaccines Market in these regions.

MARKET PLAYERS
The reports cover key developments in the Pneumococcal Vaccines Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Pneumococcal Vaccines Market are anticipated to lucrative growth opportunities in the future with the rising demand for Pneumococcal Vaccines Market in the global market. Below mentioned is the list of few companies engaged in the Pneumococcal Vaccines Market.

The report also includes the profiles of key Pneumococcal Vaccines Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development In Past Five Years.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • GlaxoSmithKline plc.
  • Sanofi Pasteur
  • China National Biotec Group
  • Astellas Pharma Inc
  • Serum Institute of India Pvt. Ltd.
  • GAVI
  • Panacea Biotec
  • Aurobindo Pharma
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Pneumococcal Vaccines Market - By Dosage
1.3.2 Pneumococcal Vaccines Market - By End User
1.3.3 Pneumococcal Vaccines Market - By Region
1.3.3.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. PNEUMOCOCCAL VACCINES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.3. EXPERT OPINIONS
5. PNEUMOCOCCAL VACCINES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PNEUMOCOCCAL VACCINES MARKET - GLOBAL MARKET ANALYSIS
6.1. PNEUMOCOCCAL VACCINES - GLOBAL MARKET OVERVIEW
6.2. PNEUMOCOCCAL VACCINES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. PNEUMOCOCCAL VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - DOSAGE
7.1. OVERVIEW
7.2. DOSAGE MARKET FORECASTS AND ANALYSIS
7.3. SINGLE DOSE VIAL
7.3.1. Overview
7.3.2. Single Dose Vial Market Forecast and Analysis
7.4. PRE-FILLED SYRINGE
7.4.1. Overview
7.4.2. Pre-Filled Syringe Market Forecast and Analysis
8. PNEUMOCOCCAL VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. CHILDREN AGED 2 TO 10
8.3.1. Overview
8.3.2. Children aged 2 to 10 Market Forecast and Analysis
8.4. ADULTS AGED 10 TO 64
8.4.1. Overview
8.4.2. Adults aged 10 to 64 Market Forecast and Analysis
8.5. GERIATRIC AGED MORE THAN 65
8.5.1. Overview
8.5.2. Geriatric aged more than 65 Market Forecast and Analysis
9. PNEUMOCOCCAL VACCINES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Pneumococcal Vaccines Market Overview
9.1.2 North America Pneumococcal Vaccines Market Forecasts and Analysis
9.1.3 North America Pneumococcal Vaccines Market Forecasts and Analysis - By Dosage
9.1.4 North America Pneumococcal Vaccines Market Forecasts and Analysis - By End User
9.1.5 North America Pneumococcal Vaccines Market Forecasts and Analysis - By Countries
9.1.5.1 United States Pneumococcal Vaccines Market
9.1.5.1.1 United States Pneumococcal Vaccines Market by Dosage
9.1.5.1.2 United States Pneumococcal Vaccines Market by End User
9.1.5.2 Canada Pneumococcal Vaccines Market
9.1.5.2.1 Canada Pneumococcal Vaccines Market by Dosage
9.1.5.2.2 Canada Pneumococcal Vaccines Market by End User
9.1.5.3 Mexico Pneumococcal Vaccines Market
9.1.5.3.1 Mexico Pneumococcal Vaccines Market by Dosage
9.1.5.3.2 Mexico Pneumococcal Vaccines Market by End User
9.1.5.4 US Pneumococcal Vaccines Market
9.1.5.4.1 US Pneumococcal Vaccines Market by Dosage
9.1.5.4.2 US Pneumococcal Vaccines Market by End User
9.2. EUROPE
9.2.1 Europe Pneumococcal Vaccines Market Overview
9.2.2 Europe Pneumococcal Vaccines Market Forecasts and Analysis
9.2.3 Europe Pneumococcal Vaccines Market Forecasts and Analysis - By Dosage
9.2.4 Europe Pneumococcal Vaccines Market Forecasts and Analysis - By End User
9.2.5 Europe Pneumococcal Vaccines Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Pneumococcal Vaccines Market
9.2.5.1.1 Germany Pneumococcal Vaccines Market by Dosage
9.2.5.1.2 Germany Pneumococcal Vaccines Market by End User
9.2.5.2 France Pneumococcal Vaccines Market
9.2.5.2.1 France Pneumococcal Vaccines Market by Dosage
9.2.5.2.2 France Pneumococcal Vaccines Market by End User
9.2.5.3 Italy Pneumococcal Vaccines Market
9.2.5.3.1 Italy Pneumococcal Vaccines Market by Dosage
9.2.5.3.2 Italy Pneumococcal Vaccines Market by End User
9.2.5.4 Spain Pneumococcal Vaccines Market
9.2.5.4.1 Spain Pneumococcal Vaccines Market by Dosage
9.2.5.4.2 Spain Pneumococcal Vaccines Market by End User
9.2.5.5 United Kingdom Pneumococcal Vaccines Market
9.2.5.5.1 United Kingdom Pneumococcal Vaccines Market by Dosage
9.2.5.5.2 United Kingdom Pneumococcal Vaccines Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Pneumococcal Vaccines Market Overview
9.3.2 Asia-Pacific Pneumococcal Vaccines Market Forecasts and Analysis
9.3.3 Asia-Pacific Pneumococcal Vaccines Market Forecasts and Analysis - By Dosage
9.3.4 Asia-Pacific Pneumococcal Vaccines Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Pneumococcal Vaccines Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Pneumococcal Vaccines Market
9.3.5.1.1 Australia Pneumococcal Vaccines Market by Dosage
9.3.5.1.2 Australia Pneumococcal Vaccines Market by End User
9.3.5.2 China Pneumococcal Vaccines Market
9.3.5.2.1 China Pneumococcal Vaccines Market by Dosage
9.3.5.2.2 China Pneumococcal Vaccines Market by End User
9.3.5.3 India Pneumococcal Vaccines Market
9.3.5.3.1 India Pneumococcal Vaccines Market by Dosage
9.3.5.3.2 India Pneumococcal Vaccines Market by End User
9.3.5.4 Japan Pneumococcal Vaccines Market
9.3.5.4.1 Japan Pneumococcal Vaccines Market by Dosage
9.3.5.4.2 Japan Pneumococcal Vaccines Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Pneumococcal Vaccines Market Overview
9.4.2 Middle East and Africa Pneumococcal Vaccines Market Forecasts and Analysis
9.4.3 Middle East and Africa Pneumococcal Vaccines Market Forecasts and Analysis - By Dosage
9.4.4 Middle East and Africa Pneumococcal Vaccines Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Pneumococcal Vaccines Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Pneumococcal Vaccines Market
9.4.5.1.1 South Africa Pneumococcal Vaccines Market by Dosage
9.4.5.1.2 South Africa Pneumococcal Vaccines Market by End User
9.4.5.2 Saudi Arabia Pneumococcal Vaccines Market
9.4.5.2.1 Saudi Arabia Pneumococcal Vaccines Market by Dosage
9.4.5.2.2 Saudi Arabia Pneumococcal Vaccines Market by End User
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. PNEUMOCOCCAL VACCINES MARKET, KEY COMPANY PROFILES
11.1. MERCK AND CO., INC
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. PFIZER INC
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. GLAXOSMITHKLINE PLC
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. SANOFI PASTEUR
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. CHINA NATIONAL BIOTEC GROUP
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. ASTELLAS PHARMA INC
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. SERUM INSTITUTE OF INDIA PVT. LTD
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. GAVI
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. PANACEA BIOTEC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. AUROBINDO PHARMA
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

- Merck & Co. , Inc.
- Pfizer Inc.
- GlaxoSmithKline plc.
- Sanofi Pasteur
- China National Biotec Group
- Astellas Pharma Inc
- Serum Institute of India Pvt. Ltd.
- GAVI
- Panacea Biotec
- Aurobindo Pharma
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book